Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Asset Utilization Ratio (2016 - 2025)

Fortress Biotech has reported Asset Utilization Ratio over the past 13 years, most recently at 0.36 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.36 for Q4 2025, down 12.47% from a year ago — trailing twelve months through Dec 2025 was 0.36 (down 12.47% YoY), and the annual figure for FY2025 was 0.38, up 8.47%.
  • Asset Utilization Ratio for Q4 2025 was 0.36 at Fortress Biotech, up from 0.35 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for FBIO hit a ceiling of 0.61 in Q3 2024 and a floor of 0.05 in Q1 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.18 (2022), compared with a mean of 0.23.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 127.63% in 2021 and later surged 1742.73% in 2022.
  • Fortress Biotech's Asset Utilization Ratio stood at 0.16 in 2021, then decreased by 15.8% to 0.13 in 2022, then soared by 148.25% to 0.33 in 2023, then increased by 22.18% to 0.41 in 2024, then fell by 12.47% to 0.36 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.36 (Q4 2025), 0.35 (Q3 2025), and 0.34 (Q2 2025) per Business Quant data.